Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin Calcium

NCT00681395 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Adverse Events
Pharmacokinetic

Interventions

DRUG: ABT-143
DRUG: ABT-335
DRUG: Rosuvastatin

Sponsor

AstraZeneca